Evidence map›Paper›PMID 30107871›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2018

Healthcare-associated pneumonia in acute care hospitals in European Union/European Economic Area countries: an analysis of data from a point prevalence survey, 2011 to 2012.

Jan Walter, Sebastian Haller, Chantal Quinten, Tommi Kärki, Benedikt Zacher, Tim Eckmanns, Muna Abu Sin, Diamantis Plachouras, Pete Kinross, Carl Suetens and 1 more

Abstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Mechanisms involved in cefiderocol resistance in FrenchAntimicrobial agents and chemotherapy · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Preventability of Hospital Deaths in Patients With Non-Ventilator Hospital-Acquired Pneumonia.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  11. Review
  12. Article
  13. Vaccines · 2024
    Review
  14. Novel Antibiotics for Gram-Negative Nosocomial Pneumonia.Antibiotics (Basel, Switzerland) · 2024
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jan WalterUnit of Healthcare-associated Infections, Surveillance of Antibiotic Resistance and Consumption, Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Sebastian HallerUnit of Healthcare-associated Infections, Surveillance of Antibiotic Resistance and Consumption, Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Chantal QuintenSurveillance and Response Support Unit, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Tommi KärkiSurveillance and Response Support Unit, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Benedikt ZacherUnit of Healthcare-associated Infections, Surveillance of Antibiotic Resistance and Consumption, Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Tim EckmannsUnit of Healthcare-associated Infections, Surveillance of Antibiotic Resistance and Consumption, Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Muna Abu SinUnit of Healthcare-associated Infections, Surveillance of Antibiotic Resistance and Consumption, Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Diamantis PlachourasSurveillance and Response Support Unit, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Pete KinrossSurveillance and Response Support Unit, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Carl SuetensSurveillance and Response Support Unit, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
ECDC PPS study groupThe members of the ECDC PPS study group are listed at the end of the article.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An aim of the ECDC point prevalence survey (PPS) in European Union/European Economic Area acute care hospitals was to acquire standardised healthcare-associated infections (HAI) data. We analysed one of the most common HAIs in the ECDC PPS, healthcare-associated pneumonia (HAP). Standardised HAI case definitions were provided and countries were advised to recruit nationally representative subsets of hospitals. We calculated 95% confidence intervals (CIs) around prevalence estimates and adjusted for clustering at hospital level. Of 231,459 patients in the survey, 2,902 (1.3%; 95% CI: 1.2-1.3) fulfilled the case definition for a HAP. HAPs were most frequent in intensive care units (8.1%; 95% CI: 7.4-8.9) and among patients intubated on the day of the survey (15%; 95% CI: 14-17; n = 737 with HAP). The most frequently reported microorganism was

Indexed as

AdolescentAdultAgedAged, 80 and overAnti-Bacterial AgentsAnti-Infective AgentsChildChild, PreschoolCross InfectionEuropeEuropean UnionFemaleGram-Negative BacteriaGram-Positive BacteriaHealthcare-Associated PneumoniaHumansAnti-Bacterial AgentsAnti-Infective Agentsantibiotic useantimicrobial resistanceepidemiologyEuropehealthcare-associated infectionsinfection prevention and controlpneumoniapoint prevalence surveysurveillance

Identifiers

PMID30107871
PMCPMC6092912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.